Provided by Tiger Trade Technology Pte. Ltd.

Capstone Therapeutics Corp

0.1492
+0.00523.61%
Post-market: 0.1425-0.0067-4.49%19:46 EDT
Volume:3.37M
Turnover:489.74K
Market Cap:3.25M
PE:-0.06
High:0.1544
Open:0.1399
Low:0.1366
Close:0.1440
52wk High:1.50
52wk Low:0.1366
Shares:21.75M
Float Shares:12.32M
Volume Ratio:0.15
T/O Rate:27.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4235
EPS(LYR):-4.1220
ROE:-114.21%
ROA:-3.47%
PB:0.26
PE(LYR):-0.04

Loading ...

Capstone Therapeutics announces unregistered sale of shares under USD 20 million equity line

Reuters
·
Jun 12

Capstone announces commercial wins via Carolina Stone subsidiary

TIPRANKS
·
Jun 01

Capstone expands D.R. Horton stone installation work to 19 Raleigh communities

Reuters
·
Jun 01

PAA announces Tsinghua University partnership, releases report spotlighting Asia's patient philanthropic risk capital

Belle Neo
·
May 21

Capstone Holding Q1 EPS $(0.21) Misses $(0.19) Estimate, Sales $12.636M Beat $10.803M Estimate

Benzinga Earnings
·
May 20

Capstone Holding Corp: Reaffirms FY2026 Guidance

THOMSON REUTERS
·
May 20

Capstone Holding Corp: Business Momentum in April and May Indicates That End-Market Conditions Have Improved Materially

THOMSON REUTERS
·
May 20

Capstone Reports Q1 2026 Results: Revenue up 60%, Gross Profit up 124%, Best Q1 Gross Margin in Four Years

THOMSON REUTERS
·
May 20

Press Release: Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years

Dow Jones
·
May 20

Capstone net loss widens to $1.92 million in Q1 FY26; net sales rise 60% to $12.64 million

Reuters
·
May 20

Capstone Holding delays Q1 10-Q filing, targets May 20 release

Reuters
·
May 16

Capstone Holding Corp - Expects Positive Ebitda Run-Rate Beginning in Q2 FY2026

THOMSON REUTERS
·
May 06

Capstone Publishes Investor Faq Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance

THOMSON REUTERS
·
May 06

Capstone reaffirms FY2026 revenue outlook at $72.1 million, EBITDA at $3.8 million

Reuters
·
May 06

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

GlobeNewswire
·
Apr 28

Capstone Announces Investor Faq Focused on 2026 Guidance and Earnings

THOMSON REUTERS
·
Apr 21

Press Release: Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings

Dow Jones
·
Apr 21

Capstone Therapeutics cuts conversion price to $0.57 on $500,000 of note principal

Reuters
·
Apr 17

Capstone Holding Q4 Adj. EPS $(1.00) Misses $(0.13) Estimate, Sales $12.762M Miss $12.801M Estimate

Benzinga Earnings
·
Apr 16

Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4X Ebitda Growth in 2026

THOMSON REUTERS
·
Apr 16